Trexquant Investment LP Vanda Pharmaceuticals Inc. Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

A detailed history of Trexquant Investment LP transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 204,447 shares of VNDA stock, worth $940,456. This represents 0.01% of its overall portfolio holdings.

Number of Shares

204,447

Previous 71,834 184.61%

Holding current value

$940,456

Previous $405,000 136.54%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.61 - $6.34 $611,345 - $840,766	132,613 Added 184.61%	204,447 $958,000
Q2 2024 Aug 13, 2024	BUY	$3.91 - $6.5 $280,870 - $466,921	71,834 New	71,834 $405,000
Q4 2023 Feb 09, 2024	SELL	$3.38 - $4.58 $573,724 - $777,413	-169,741 Reduced 61.89%	104,511 $441,000
Q3 2023 Nov 13, 2023	BUY	$4.28 - $6.57 $1.12 Million - $1.72 Million	262,088 Added 2154.62%	274,252 $1.18 Million
Q2 2023 Aug 11, 2023	SELL	$5.9 - $6.95 $220,028 - $259,186	-37,293 Reduced 75.4%	12,164 $80,000
Q1 2023 May 15, 2023	SELL	$6.18 - $7.99 $75,921 - $98,157	-12,285 Reduced 19.9%	49,457 $335,000
Q4 2022 Feb 13, 2023	BUY	$6.87 - $10.96 $204,863 - $326,827	29,820 Added 93.42%	61,742 $456,000
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $27,829 - $34,668	2,948 Added 10.17%	31,922 $315,000
Q2 2022 Aug 11, 2022	SELL	$9.31 - $11.84 $383,599 - $487,843	-41,203 Reduced 58.71%	28,974 $316,000
Q1 2022 May 13, 2022	BUY	$10.84 - $16.55 $447,193 - $682,753	41,254 Added 142.63%	70,177 $794,000
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $453,801 - $611,432	28,923 New	28,923 $454,000
Q2 2021 Aug 12, 2021	SELL	$15.71 - $21.51 $241,824 - $331,103	-15,393 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$13.42 - $20.28 $7,716 - $11,661	575 Added 3.88%	15,393 $231,000
Q4 2020 Feb 11, 2021	SELL	$9.77 - $13.81 $380,160 - $537,360	-38,911 Reduced 72.42%	14,818 $195,000
Q3 2020 Nov 06, 2020	BUY	$9.32 - $12.02 $30,448 - $39,269	3,267 Added 6.47%	53,729 $519,000
Q2 2020 Aug 07, 2020	BUY	$9.66 - $12.02 $487,462 - $606,553	50,462 New	50,462 $577,000
Q4 2019 Feb 12, 2020	SELL	$12.38 - $17.47 $368,924 - $520,605	-29,800 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$12.27 - $15.79 $105,620 - $135,920	8,608 Added 40.62%	29,800 $396,000
Q2 2019 Aug 09, 2019	BUY	$13.37 - $18.85 $283,337 - $399,469	21,192 New	21,192 $299,000
Q4 2018 Feb 13, 2019	SELL	$18.97 - $31.47 $433,217 - $718,680	-22,837 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$18.25 - $23.0 $213,214 - $268,709	11,683 Added 104.74%	22,837 $524,000
Q2 2018 Aug 07, 2018	BUY	$13.95 - $19.15 $155,598 - $213,599	11,154 New	11,154 $212,000

Others Institutions Holding VNDA

# of Institutions

159

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $260M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Vanda Pharmaceuticals Inc. Transaction History